Completed PHASE4 INTERVENTIONAL 2-arm NCT01913964

Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-α2b Plus Ribavirin

Sponsor: University of Catania

Conditions Fatigue Fatigue in Workers With Chronic C Hepatitis Work Productivity and Activity Impairment in Workers With Chronic C Hepatitis

Interventions Acetylcarnitine Placebo

Updated 5 times since 2017 Last updated: Jul 31, 2013 Started: Oct 31, 1997 Primary completion: Oct 31, 1997 Completion: Oct 31, 1997

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Fatigue and Fatigue in Workers With Chronic C Hepatitis and is currently completed. University of Catania leads this study, which shows 5 recorded versions since 1997 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

Oct 1997

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Catania

Data source: University of Catania

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.